| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 9.86% on an annualized basis producing an average annual return of 20.63%. Currently, Vertex Pharmaceuticals has a market capitalization of $110.28 billion.
Buying $100 In VRTX: If an investor had bought $100 of VRTX stock 10 years ago, it would be worth $635.73 today based on a price of $427.34 for VRTX at the time of writing.
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: VRTX
